Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

South Atlantic Industries

This article was originally published in The Tan Sheet

Executive Summary

Former exec pleads guilty in Greenville, S.C. federal court Sept. 24 to misbranding OTCs. Roger Perry was president of firm which purported to make generic cough syrup, cold formulas, liquid antacid and stomach remedies from March 1997 to March 1998, U.S. Attorney's Office in Greenville says. SAI produced drugs without proper actives and Perry "caused employees...to purchase similar generic products from drug stores or other retail outlets, repackage the products in South Atlantic Industries bottles and submit these as 'samples' of real products to potential customers and to independent laboratories for analysis," U.S. Attorney says. Perry faces up to five years in prison, $250,000 fine. FDA says SAI ceased operations following a 1998 injunction filed by the agency stemming from GMP problems
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS093097

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel